ArticleFrontiers in public health2022
Taking on the Commercial Determinants of Health at the level of actors, practices and systems.
Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Healthy Ageing without Health Equity? Capability, Justice, and Ageing Governance in the UN Decade.Journal of bioethical inquiry · 2026Article
- Commercial practices of the arms industry and implications for global public health: a scoping review.Globalization and health · 2026Article
- Confronting corporate power: addressing commercial determinants of health and the rising non-communicable disease epidemic in South-East Asia.BMJ global health · 2026Review
- "Who the hell is upstream pushing them all in?" Reclaiming public health's defining metaphor to counter the commercial determinants of health.PLOS global public health · 2026Article
- Do ESG Frameworks Capture Corporate Health Impacts? An Analysis of the Food and Beverage Industry.International journal of environmental research and public health · 2025Article
- Understanding Global Health Inequality and Inequity: Causes, Consequences, and the Path Toward Justice in Healthcare.Public health challenges · 2025Review
- Article
- Managing engagement among public, private and civil society actors participating in NewTools: a research partnership on food profiling.Public health nutrition · 2025Article
- Toward Monitoring and Addressing the Commercial Determinants of Health: Where Can We Go From Here?The Milbank quarterly · 2025Article
- Health systems as human systems: reflexivity, relationships, and resilience in the pursuit of the SDGs.Frontiers in public health · 2025Article
- Watered down: a cross-case political economy analysis of sugar-sweetened beverage taxes in Vanuatu and Fiji.Health promotion international · 2024Article
- Conducting industry informant interviews to advance healthy food retail initiatives: challenges, opportunities, and lessons.Health promotion international · 2024Article
- CPR training as a gender and rights-based healthcare issue.Health promotion international · 2024Observational
- World health order.Journal of global health · 2024Article
- The use of private regulatory measures to create healthy food retail environments: a scoping review.Public health nutrition · 2024Article
- What Are Healthy Societies? A Thematic Analysis of Relevant Conceptual Frameworks.International journal of health policy and management · 2023Article
- Protecting, promoting and supporting breastfeeding in all policies: reframing the narrative.Frontiers in public health · 2023Article
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tackling the Commercial Determinants of Health (CDoH) is necessary for progress on health equity and will determine whether or not the health-related targets of the SDGs are met. We present a simple visual heuristic of three core aspects of CDoH: commercial actors, commercial practices, and system-level dynamics (which commercial actors influence and perpetuate). We use this heuristic to highlight key research gaps, in particular the need for more voices and evidence on CDoH from the Global South, particularly on what works to curb harmful impacts. We also propose an agenda to address CDoH and actions for different stakeholders. While efforts to curb specific commercial practices are important, far more attention and effort are needed at the systems level, as they can fundamentally shift the way power is distributed in society to improve health equity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.